MindMed to Engage in Canaccord Genuity Growth Event
Company Announcements

MindMed to Engage in Canaccord Genuity Growth Event

Story Highlights

Mind Medicine (MNMD) has released an update.

Mind Medicine (MindMed) Inc., a pioneering biopharmaceutical company in the brain health sector, has announced their upcoming participation in a fireside chat at Canaccord Genuity’s 44th Annual Growth Conference. The event, which is set to take place in Boston, will be accessible via webcast with replays available for 90 days post-event on the company’s Investor Relations website.

For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyMind Medicine price target raised to $16 from $14 at Canaccord
TipRanks Auto-Generated NewsdeskMindMed Advances Phase 3 Trials in Mental Health
TipRanks Canadian Auto-Generated NewsdeskMind Medicine’s Financial Health and Phase 3 Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App